Security key
107930109
- Security type / class
- Equity / NULL
- Total 13F shares
- 1,000
- Total 13F value
- $570
- Share change
- +1,000
- SEC-reported price per share
- $0.57
- Number of holders
- 1
- Value change
- +$570
- Number of buys
- 1
Report period
Q2 2025
Institutions
1
Top holders
0
BCTX full security history
Ownership snapshot
BriaCell Therapeutics Corp. SEC filings
BriaCell Therapeutics Corp. company facts
Broader feeds
Ownership snapshot
Top reported holders of BCTX - BriaCell Therapeutics Corp. - NULL (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
3i, LP
Disclosed value leader
Marc Lustig
Comparable rows
1/15
Latest evidence
31 Mar 2025
13D/G
3/4/5
13F
Lead comparable stake: 4.9%
14 rows are not safely comparable across share classes.
13D/G row: 3i, LP
Showing 1-6 of 15 holder rows.
Quick read
3i, LP leads the comparable SEC ownership view at 4.9%.
1 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens 3i, LP's linked filing trail.
Comparable ownership
Top 1
3i, LP
4.9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| 3i, LP |
13D/G
|
4.9%
Reported 13D/G
· 31 Mar 2025
|
$872,128
190,006 shares
|
-$821,582 | 31 Mar 2025 |
| Marc Lustig |
3/4/5
Director, 10%+ Owner
|
—
mixed-class rows
|
$5,632,601
3,445,870 shares
mixed-class rows
|
— | 14 May 2024 |
| Jamieson Bondarenko |
3/4/5
Chairman, Director
|
—
denominator unverified
|
$777,940
169,856 shares
|
— | 28 Dec 2022 |
| UBS Group AG |
13F
Company
|
—
mixed-class rows
|
$69,865
21,755 shares
mixed-class rows
|
— | 31 Mar 2025 |
| William V Williams |
3/4/5
President, CEO, Director
|
—
denominator unverified
|
$57,816
29,802 shares
|
— | 23 Dec 2022 |
| Vaughn C. Embro-Pantalony |
3/4/5
Director
|
—
denominator unverified
|
$43,620
9,524 shares
|
— | 01 Aug 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Archived quarter
Historical 13F summary for Q2 2025
This older quarter remains available as an indexed ownership summary. Detailed holder rows are no longer kept in the hot table for this period.